The inaugural Eva Kolling Research Day was staged within Royal North Shore Hospital, providing the perfect chance to celebrate the vision and generosity of a true pioneer. Established in 1920, the Kolling Institute is the oldest medical research institute in New South Wales. It has been at the forefront of cutting-edge research for more than a hundred years, with its founding director Dr W. Wilson .....
Read more

Researchers from Royal North Shore Hospital and the Kolling Institute will lead Australia’s first study of whole-body screening for young people with neurofibromatosis type 1. Led by Dr Sue-Faye Siow from the department of clinical genetics, the study was awarded a grant through the RNSH Campus Research Grants Scheme, and an additional $30,000 in support from the NORTH Foundation. Neurofibromatosis.....
Read more

We would like to congratulate one of our emerging leaders at the Kolling Institute who has received a prestigious award at an international conference in Melbourne. In her final year of her PhD, Caitlin Fenech has been presented with a President’s Special Commendation award at the 36th World Congress of Neuropsychopharmacology, CINP-AsCNP 2025. Caitlin has also taken to the stage today to deliver a.....
Read more

International Clinical Trials Day provided the chance to recognise the many people contributing to our life-changing clinical trials. Two key events were staged to mark the day, including a presentation in the Kolling auditorium from leading clinical trial investigators, and a public display within Royal North Shore Hospital.  More than 300 trials are underway across Northern Sydney including .....
Read more

Check out our latest newsletter Researchers target sleep for muscle pain relief Landmark clinical trial to improve lung cancer treatment Pioneering Muscle Map project receives funding support Travel awards for emerging research leaders And much more:  Click here:
Read more

Leading Royal North Shore Hospital clinician researcher Professor Nick Pavlakis and Professor Ben Solomon have secured a $14.7 million MRFF grant for a clinical trial which will explore the use of a liquid biopsy to inform treatment for lung cancer. The condition is the leading cause of cancer death in Australia and worldwide, claiming an estimated 9,000 lives in Australia each year. The pioneering.....
Read more

Five emerging researchers will have the chance to develop their skills and raise the international profile of the Kolling Institute thanks to generous funding from the Skipper Jacobs Charitable Trust. Academic Director Professor James Elliott said a total of $40,000 will be shared by the early-to-mid career researchers to increase their research impact and strengthen their collaborations. Pablo Cru.....
Read more

New research from the University of Sydney and the Kolling Institute reveals that obesity, having a knee injury and occupational risks such as shift work and lifting heavy loads are primary causes of knee osteoarthritis. Published in Osteoarthritis and Cartilage, the study was led by Dr Vicky Duong and A/Professor Christina Abdel Shaheed from Sydney Musculoskeletal Health, a joint initiative betwee.....
Read more

An innovative study, led by a team of researchers from the Kolling Institute, has the potential to change the way osteoarthritis and low back pain are managed. More than $4.7 million has been awarded to the project through the Medical Research Future Fund’s program for early to mid-career researchers. Study lead Associate Professor Michelle Hall said we know that chronic muscle pain and poor sleep .....
Read more

Thank you to Northside Living News for profiling an exciting clinical trial to prevent knee osteoarthritis. Our researchers at the Kolling Institute are now recruiting to the large-scale trial which will offer long-term support to lose weight and avoid knee osteoarthritis all together. If you would like to know more about the trial and to sign up, click here: To read about the details in North.....
Read more